Largest biotech companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at SEK 231.1B, ahead of Biogen (SEK 185.8B) and Amgen (SEK 88.1B). Figures as of 20 Nov 2026, 07:46 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Gilead SciencesSEK 231.1B
- Median
- SEK 16.3B
- Combined market value
- SEK 7.48T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SEK 231.1B | SEK 2.1T | SEK 1,694.85 | 1.45% down | 35% up | ||
| 2 | BiogenBIIB · Health Care | SEK 185.8B | SEK 371.8B | SEK 2,515.15 | 1.70% down | 49% up | ||
| 3 | AmgenAMGN · Health Care | SEK 88.1B | SEK 2.42T | SEK 4,466.07 | 1.14% down | 32% up | ||
| 4 | ModernaMRNA · Health Care | SEK 88B | SEK 820.8B | SEK 2,028.67 | 1.29% up | 780% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | SEK 33.1B | SEK 161.3B | SEK 1,593.69 | 3.85% down | 17% up | ||
| 6 | VaxcytePCVX · Health Care | SEK 27.3B | SEK 94B | SEK 593.96 | 0.27% down | 23% up | ||
| 7 | ExelixisEXEL · Health Care | SEK 22B | SEK 163.5B | SEK 669.98 | 3.60% down | 63% up | ||
| 8 | Bio-TechneTECH · Health Care | SEK 21.5B | SEK 116.2B | SEK 739.90 | 0.07% down | 24% up | ||
| 9 | RepligenRGEN · Health Care | SEK 21.4B | SEK 110.8B | SEK 1,733.12 | 1.38% down | 12% up | ||
| 10 | Revolution MedicinesRVMD · Health Care | SEK 16.6B | SEK 351B | SEK 1,622.59 | 0.24% down | 129% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | SEK 16.1B | SEK 103.7B | SEK 1,215.09 | 1.44% down | 87% up | ||
| 12 | Krystal BiotechKRYS · Health Care | SEK 12.4B | SEK 95.2B | SEK 3,214.24 | 0.15% up | 54% up | ||
| 13 | ImmunovantIMVT · Health Care | SEK 8.7B | SEK 68.5B | SEK 330.97 | 1.96% down | 46% up | ||
| 14 | CG OncologyCGON · Health Care | SEK 7.7B | SEK 74.5B | SEK 833.53 | 2.38% up | 97% up | ||
| 15 | Twist BioscienceTWST · Health Care | SEK 4.8B | SEK 77.5B | SEK 1,136.01 | 4.07% down | 346% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | SEK 2.5B | SEK 62.5B | SEK 512.64 | 4.94% up | 26% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | SEK 2.2B | SEK 46.2B | SEK 285.48 | 1.44% down | 74% up | ||
| 18 | Kodiak SciencesKOD · Health Care | SEK 1.6B | SEK 65.2B | SEK 996.37 | 0.09% up | 399% up | ||
| 19 | Halozyme TherapeuticsHALO · Health Care | SEK 496.8M | SEK 108B | SEK 946.91 | 2.88% down | 39% up | ||
| 20 | ImmunityBioIBRX · Health Care | -SEK 5.1B | SEK 71.1B | SEK 66.87 | 1.94% down | 232% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1775 SEK).
Questions and answers
Which biotech companies in the United States rank first by net assets?
Gilead Sciences (SEK 231.1B), Biogen (SEK 185.8B) and Amgen (SEK 88.1B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 07:46 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by net assets.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by net assets have a combined market value of SEK 7.48T as of 20 Nov 2026, 07:46 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.